Envista (NVST) Revenue & Revenue Breakdown
Envista Revenue Highlights
Latest Revenue (Q)
$669.90M
Main Segment (Y)
Specialty Products and Technologies
Main Geography (Y)
UNITED STATES
Envista Revenue by Period
Envista Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | -100.00% |
| 2023-12-31 | $2.57B | -0.10% |
| 2022-12-31 | $2.57B | 2.40% |
| 2021-12-31 | $2.51B | 9.94% |
| 2020-12-31 | $2.28B | -17.07% |
| 2019-12-31 | $2.75B | -3.27% |
| 2018-12-31 | $2.84B | 1.20% |
| 2017-12-31 | $2.81B | 0.92% |
| 2016-12-31 | $2.79B | - |
Envista generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Envista Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-26 | $669.90M | -1.79% |
| 2025-06-27 | $682.10M | 10.57% |
| 2025-03-28 | $616.90M | -5.51% |
| 2024-12-31 | $652.90M | 8.64% |
| 2024-09-27 | $601.00M | -5.07% |
| 2024-06-28 | $633.10M | 1.52% |
| 2024-03-29 | $623.60M | -3.41% |
| 2023-12-31 | $645.60M | 2.27% |
| 2023-09-29 | $631.30M | -4.70% |
| 2023-06-30 | $662.40M | 5.61% |
| 2023-03-31 | $627.20M | -5.08% |
| 2022-12-31 | $660.80M | 4.71% |
| 2022-09-30 | $631.10M | -2.28% |
| 2022-07-01 | $645.80M | 2.28% |
| 2022-04-01 | $631.40M | -3.13% |
| 2021-12-31 | $651.80M | 7.33% |
| 2021-10-01 | $607.30M | -4.69% |
| 2021-07-02 | $637.20M | 4.02% |
| 2021-04-02 | $612.60M | -0.60% |
| 2020-12-31 | $616.30M | 12.63% |
| 2020-10-02 | $547.20M | 51.16% |
| 2020-07-03 | $362.00M | -33.85% |
| 2020-04-03 | $547.20M | -24.05% |
| 2019-12-31 | $720.50M | 9.28% |
| 2019-09-27 | $659.30M | -7.41% |
| 2019-06-30 | $712.10M | 7.94% |
| 2019-03-31 | $659.70M | -13.08% |
| 2018-12-31 | $759.00M | 11.70% |
| 2018-09-30 | $679.50M | -7.35% |
| 2018-06-30 | $733.40M | 9.04% |
| 2018-03-31 | $672.60M | - |
Envista generated $669.90M in revenue during Q3 2025, up -1.79% compared to the previous quarter, and up 105.81% compared to the same period a year ago.
Envista Revenue Breakdown
Envista Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Equipment and Consumables | $894.20M | $924.10M | - | - | - |
| Specialty Products and Technologies | $1.62B | $1.64B | - | - | - |
| Equipment Sales | - | - | $421.60M | $441.00M | $687.90M |
| Consumables | - | - | $2.15B | $2.07B | $1.59B |
Envista's latest annual revenue breakdown by segment (product or service), as of Dec 24: Specialty Products and Technologies (64.38%), and Equipment and Consumables (35.62%).
Quarterly Revenue by Product
| Product/Service | Dec 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Apr 22 | Dec 21 | Oct 21 | Jul 21 | Apr 21 | Dec 20 | Oct 20 | Jul 20 | Apr 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equipment and Consumables | $679.30M | $214.90M | $446.90M | $231.80M | $245.40M | $391.70M | $341.50M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Specialty Products and Technologies | $1.21B | $408.70M | $825.90M | $399.50M | $417.00M | $328.80M | $317.80M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Consumables | - | - | - | - | - | $535.50M | $541.80M | $531.00M | $544.80M | $529.90M | $526.30M | $493.70M | $534.50M | $514.90M | $501.00M | $459.90M | $255.30M | $377.90M | - | - |
| Equipment Sales | - | - | - | - | - | $91.70M | $119.00M | $100.10M | $101.00M | $101.50M | $125.50M | $113.60M | $205.60M | $194.30M | $231.30M | $180.60M | $106.70M | $169.30M | - | - |
Envista's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Specialty Products and Technologies (64.00%), and Equipment and Consumables (36.00%).
Envista Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| CHINA | $193.50M | $205.70M | $222.20M | $236.70M | $215.60M |
| All Other Countries | $1.11B | $1.15B | $1.08B | $1.05B | $908.90M |
| UNITED STATES | $1.20B | $1.21B | $1.26B | $1.22B | $1.01B |
| GERMANY | - | - | - | - | $144.60M |
Envista's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (47.91%), All Other Countries (44.38%), and CHINA (7.71%).
Quarterly Revenue by Country
| Country | Sep 25 | Jun 25 | Mar 25 | Sep 24 | Mar 24 | Sep 23 | Dec 21 | Dec 19 |
|---|---|---|---|---|---|---|---|---|
| North America | $348.10M | $347.90M | $324.40M | $319.50M | $318.70M | $332.00M | $333.50M | $351.20M |
| Western Europe | $139.10M | $154.10M | $143.30M | $109.30M | $148.30M | $119.50M | $135.40M | $160.00M |
Envista's latest quarterly revenue breakdown by geography, as of Sep 25: North America (71.45%), and Western Europe (28.55%).
Envista Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| XRAY | DENTSPLY SIRONA | $3.79B | $904.00M |
| ALHC | Alignment Healthcare | $2.70B | $993.70M |
| ICUI | ICU Medical | $2.38B | $536.99M |
| CON | Concentra Group Parent | $1.90B | $572.80M |
| PRVA | Privia Health Group | $1.74B | $580.42M |
| SUPN | Supernus Pharmaceuticals | $661.82M | $192.10B |
| RARE | Ultragenyx Pharmaceutical | $560.23M | $159.93M |
| GRAL | GRAIL | $93.11M | $36.19M |
| NVST | Envista | - | $669.90M |
| APGE | Apogee Therapeutics | - | - |
| DYN | Dyne Therapeutics | - | - |